The 3D bioprinting market had a global size of USD 1.27 Billion in 2022, with an expected growth to USD 10.35 Billion by 2032, and a projected revenue compound annual growth rate (CAGR) of 26.2% during the forecast period. Market growth is primarily driven by factors such as the increasing demand for organ transplants, the expanding utilization of 3D bioprinting in the pharmaceutical and...